Latham & Watkins Reps Eli Lilly In Alnara Acquisition
Eli Lilly & Co. has inked a deal to acquire privately held biotechnology company Alnara Pharmaceuticals Inc., the companies said Friday....To view the full article, register now.
Already a subscriber? Click here to view full article